Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer
NCT05698992 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-15
Summary
This study aims to develop and evaluate a model for systematic and evidence-based cancer rehabilitation for people with esophageal and gastric cancer to provide conditions for a better quality of life and fewer cancer-related symptoms.
Conditions
- Esophageal Cancer
- Esophageal Neoplasms
- Gastric Cancer
- Stomach Neoplasm
Interventions
- OTHER
-
evidence-based individualized rehabilitation
The experimental group will receive structured individualized assessment based on physical, psychological or social needs and will be offered evidence-based interventions to promote rehabilitation and recovery.
Sponsors & Collaborators
- collaborator OTHER
-
Region Skane
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-27
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT06889402 ·Status: NOT_YET_RECRUITING
-
Rehabilitative Strategies Following Oesophageal Cancer
NCT03314311 ·Status: COMPLETED ·Phase: NA
-
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
NCT06872515 ·Status: RECRUITING ·Phase: NA
-
Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus
NCT02991547 ·Status: TERMINATED
-
Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.
NCT02241499 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
NCT00978549 ·Status: COMPLETED ·Phase: PHASE3
-
Esophagectomy With or Without Prior Ischemic Gastric Preconditioning
NCT02457299 ·Status: TERMINATED ·Phase: NA
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
NCT00393068 ·Status: COMPLETED ·Phase: PHASE2
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
NCT00561197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia
NCT01362127 ·Status: COMPLETED ·Phase: PHASE2
-
International Nutrition Audit in FORegut TuMors
NCT02829489 ·Status: COMPLETED
-
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002884 ·Status: UNKNOWN ·Phase: PHASE3
-
Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer
NCT03285035 ·Status: UNKNOWN
-
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
NCT04929392 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Effect of Ablation Therapy on Barrett's Esophagus
NCT00587314 ·Status: ENROLLING_BY_INVITATION
-
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
NCT00193128 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
NCT00570531 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility Study of Fiducial Markers in Oesophageal Cancer
NCT02403050 ·Status: UNKNOWN
-
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
NCT01769508 ·Status: TERMINATED ·Phase: PHASE2
-
Chemoradiotherapy for Advanced Esophageal Cancer
NCT02297217 ·Status: RECRUITING ·Phase: PHASE2